Biologic therapies versus surgical management for aspirin-exacerbated respiratory disease: A review of preliminary data, efficacy, and cost
Aspirin-exacerbated respiratory disease (AERD) patients with CRSwNP suffer from reduced quality of life, reduced economic productivity, and higher risk of depression and sleep dysfunction. These patients often require frequent medical and surgical therapy, including functional endoscopic sinus surge...
Enregistré dans:
Auteurs principaux: | Alan D. Workman, Benjamin S. Bleier |
---|---|
Format: | article |
Langue: | EN |
Publié: |
KeAi Communications Co., Ltd.
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7783b942a26d4f468872f81983e19fd7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
par: Tran Locke, et autres
Publié: (2020) -
Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
par: Daniel B. Spielman, et autres
Publié: (2020) -
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments
par: Carlo Lombardi, MD, et autres
Publié: (2021) -
Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
par: Lindsey Ryan, et autres
Publié: (2020) -
The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
par: Kathleen Buchheit, et autres
Publié: (2020)